Selegiline Transdermal Patch and Insulin: Interaction Details

Brand names
Selegiline Transdermal Patch
EmsamZelapar
Insulin
AfrezzaHumulin RMyxredlin +1 more
Same medicines, other forms
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page

A close look at the Selegiline Transdermal Patch and Insulin interaction:

Share

Share this interaction

Insulin

Brand names
  • Afrezza
  • Humulin R
  • Myxredlin
  • Novolin R

We don't have a drug information page for Insulin yet. Have a question about Insulin? Ask a pharmacist, free →

What Happens When You Take Selegiline Transdermal Patch With Insulin

What can happen when they are taken together (rated Moderate)

An increased risk of

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Certain can enhance the blood glucose lowering action of hypoglycemic agents when the two are used together.12 In patients with type 2 diabetes who still retain the ability to secrete insulin, MAOIs may produce hyperinsulinemia.7

When an is started or stopped in a patient who is taking a hypoglycemic agent, blood glucose should be monitored closely. Reducing the dose of insulin or of oral hypoglycemic agents may be needed,31 and in some cases one of the two interacting drugs may need to be discontinued.4

The Selegiline Transdermal Patch and Insulin Interaction, Explained

Taking selegiline (a patch or dissolving tablet for depression or Parkinson's disease) with insulin can make your blood sugar drop lower than expected. Selegiline belongs to a group of medicines called , and some of these can boost the body's own insulin or strengthen insulin's effect. Low blood sugar can cause shakiness, sweating, hunger, confusion, or a fast heartbeat.

This is usually manageable. Your care team may check your blood sugar more often, especially when selegiline is started or stopped, and your insulin dose may need to be adjusted. Keep taking both as prescribed and talk with your pharmacist or doctor about any changes.

Interaction: , including selegiline, may potentiate the glucose-lowering effect of insulin, increasing the risk and intensity of .

  • Mechanism: unknown. -associated hyperinsulinemia has been described in type 2 diabetes with retained insulin secretory capacity.
  • Onset: rapid. Evidence: probable. Severity: moderate.
  • Management: monitor blood glucose closely when the MAOI is started or stopped. Insulin dose reduction may be needed and should be individualized. In some cases discontinuing one agent may be required.
  • Counsel patients on hypoglycemia recognition and response.

See the 8 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Selegiline Transdermal Patch and Insulin Interact

The likely mechanism

Unknown

“Unknown” here means the studies and labels behind this record do not say how the interaction happens. It does not mean the interaction is unlikely.

When two medicines can each cause the same effect, here changes in blood sugar, taking them together can add to it. That is often the reason for an interaction like this one, though the sources do not confirm it for this pair.

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Selegiline Transdermal Patch and Insulin Interaction

Your care team can manage this by tailoring your treatment and watching your blood sugar closely.

  • Blood sugar checks: your team may monitor you more closely, especially when selegiline is started or stopped.
  • Dose changes: your insulin dose may need to be adjusted and individualized by your care team. In some cases, they may decide one of the medicines should be changed.
  • What you should do: keep taking both as prescribed, and do not change any dose on your own. Tell your pharmacist or prescriber about any episodes of low blood sugar, such as shakiness, sweating, or confusion.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Selegiline Transdermal Patch or Insulin need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there anything you'd monitor while I'm on both?

Literature Reports

2 reports from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Modification of insulin and sulfonylurea hypoglycemia by monoamine-oxidase inhibitor drugs

    drugs may potentiate the hypoglycemic effects of hypoglycemic agents. Interference by MAOI drugs with the homeostatic adrenergic response to was proposed as the mechanism,5 although this mechanism was not confirmed.6 seem to induce hyperinsulinemia.7

  2. Report 2 · Study title

    Hypoglycemia caused by selegiline, an antiparkinsonian drug: can such side effects be predicted?

    In a 70-year old man with Parkinson's disease, treatment with selegiline (a specific MAO-B ) resulted in profound . The hypoglycemia occurred together with hyperinsulinemia and continued for one week after selegiline was stopped.8

Selegiline Transdermal Patch and Insulin: Common Questions

How serious is the Selegiline Transdermal Patch and Insulin interaction?

It is rated moderate. Can be significant — usually manageable with monitoring.

How is the Selegiline Transdermal Patch and Insulin interaction managed?

Your care team can manage this by tailoring your treatment and watching your blood sugar closely. Blood sugar checks: your team may monitor you more closely, especially when selegiline is started or stopped. Dose changes: your insulin dose may need to be adjusted and individualized by your care team. In some cases, they may decide one of the medicines should be changed. What you should do: keep ta… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "rapid". Effects can appear quickly, often within about 24 hours of combining the drugs.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Selegiline Transdermal Patch and Insulin Interaction

Ask in your own words about taking Selegiline Transdermal Patch and Insulin together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (8)

  1. Product Information: AMARYL(R) oral tablets, glimepiride oral tablets. Sanofi-Aventis U.S. LLC (per FDA), Bridgewater, NJ, 2013. DailyMed
  2. Product Information: Starlix(R) oral tablets, nateglinide oral tablets. Novartis Pharmaceuticals Corporation (per FDA), East Hanover, NJ, 2011. DailyMed
  3. Product Information: TOUJEO(R) subcutaneous injection, insulin glargine subcutaneous injection. sanofi-aventis (per manufacturer), Bridgewater, NJ, 2015. DailyMed
  4. Product Information: ZYVOX(R) intravenous injection, oral tablets suspension, linezolid intravenous injection, oral tablets suspension. Pfizer Inc. (per FDA), New York, NY, 2013. DailyMed
  5. Cooper AJ & Ashcroft G: Modification of insulin and sulfonylurea hypoglycemia by monoamine-oxidase inhibitor drugs. Diabetes 1967; 16:272-274. PubMed
  6. Adnitt PI: Hypoglycemic action of monoamineoxidase inhibitors (MAOI'S). Diabetes 1968; 17:628-633. DOI
  7. Bressler R, Vargas-Cord M, & Lebovitz HE: Tranylcypromine: a potent insulin secretagogue and hypoglycemic agent. Diabetes 1968; 17:617-624. PubMed
  8. Rowland MJ, Bransome ED Jr. & Hendry LB: Hypoglycemia caused by selegiline, an antiparkinsonian drug: can such side effects be predicted?. J Clin Pharmacol 1994; 34:80-85. PubMed
Was this write-up helpful?

Other Serious Interactions of Selegiline Transdermal Patch and Insulin

Also serious with Selegiline Transdermal Patch

Also serious with Insulin

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Insulin

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring.
  • Moderate Can be significant — usually manageable with monitoring. This interaction.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs. This interaction.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.